Use the menu above to jump to a segment in the document. For quick navigation, see the dosing schedule or the unwelcome indirect effects section.

Summary

Fenbendazole is a benzimidazole anthelmintic widely marketed for animals. It interferes with parasite microtubules and glucose uptake, which impairs energy production in susceptible helminths and some protozoa. In Australia it is marketed for veterinary use; it is not an approved medicine for human therapeutic use on the Therapeutic Goods Administration register.

Local formulations include small-dose sachets of granules, concentrated 10 percent oral suspensions, and larger farm-volume products for livestock. Some community and research groups have discussed potential anticancer activity, but such uses are investigational and not approved for humans. Take a look at the regulatory annotations for legal context.

Veterinary and Uses for clinical purposes

In animals, fenbendazole is used as a broad-spectrum wormer. The precise parasites treated depend on the host species and product label. Confirm diagnosis and consider local resistance patterns when choosing therapy.

• Example hookworms are Ancylostoma and Uncinaria
• Roundworms including Toxocara species
• Giardia in selected cases
• Tapeworms from some Taenia species
• Whipworms in susceptible hosts
• Strongyles and Strongyloides
• Certain lung and tissue parasites with specific formulations

Research interest in fenbendazole's effect on microtubules has led to experimental use discussions outside approved markers; these are not supported by regulatory approval or robust clinical evidence for human cancer therapy.

How to Dose and Administer

Dosing is species-, product- and parasite-specific. Always follow the product label or veterinary instruction. The examples below are indicative only.

Common dog regimen for many intestinal nematodes: approximately 50 mg per kg given once daily for three consecutive days. Other parasites or hosts might require different dosages or extended courses.

Because sachets, liquids and farm concentrates differ in strength, select a presentation that permits accurate, weight-based dosing. If you are considering any human use, consult a medical practitioner and analyze the regulatory information.

Safety, Safety procedures and Real-Time Keeping under surveillance

Consider these risk mitigation measures before and during treatment.

• Evaluate liver health: exercise caution with known hepatic disease and consider baseline and follow-up liver function testing for prolonged or repeated courses.
• Pregnancy and lactation: safety data are incomplete for some species and stages of pregnancy; seek professional advice prior to treatment.
• Confirm infection: fecal testing or other diagnostics reduce unnecessary exposure and improve treatment selection.
• Combination regimens: some investigational protocols pair fenbendazole with other agents; such regimens should only be used under clinician supervision.

Check beforehand and begin safely. the drug real time engagement and communications enable quick problem solving. section if the patient or animal is taking other medicines or supplements.

Use is contraindicated in these cases and System warnings Guidance

• Known hypersensitivity to fenbendazole or any formulation excipient
• Critical liver impairment unless benefit clearly outweighs risk and keeping track of metrics is arranged
• Uncertain safety during pregnancy in some species and formulations

If any of these conditions apply, consult a veterinarian for animals or a doctor for human health matters before you use this.

Drug incidental effects and Signs to Watch

Adverse pharmacologic effects are uncommon but possible. Reported signs include:

• Gastrointestinal upset: reduced appetite, vomiting, or diarrhea
• Transient changes in liver enzymes; rare instances of probable mild liver injury have been associated with related benzimidazoles
• Occasional transient reductions in blood cell counts after high or prolonged dosing

If you notice severe symptoms such as jaundice, very dark urine, significant weakness, bleeding or unexpected bruising, stop treatment and seek immediate veterinary or medical assessment. For instructions on suspected overdose see a drug overdose case response.

Drug Interaction Considerations

Be cautious when fenbendazole is given with other medicines, especially those processed by the liver or with narrow therapeutic indices.

• Methotrexate (MTX): theoretical two-way communication in action could affect elimination and toxicity; monitor closely if combined under professional supervision.
• Other hepatically metabolized drugs: coadministration with agents that alter liver enzyme activity or have hepatotoxic potential needs clinician review.
• Herbal and complementary products: disclose all supplements to the treating professional because contact and responses across departments improve alignment. are possible.

Guidance for a You missed a dose

If a scheduled dose is missed, administer it as soon as it is remembered unless the next dose is due shortly. Do not double up on doses to make up for a missed one. Continue the original dosing schedule.

Overdose situation and Emergency Assistance Response

A single accidental large dose is unlikely to be fatal for most species, but repeated or massive she overdoseds can cause bone marrow suppression and low blood counts. If an she overdosed is suspected, get urgent advice from emergency services, a veterinarian, or a medical practitioner and bring the product packaging or label if available.

Temporary data storage management helps organize and track items. and Handling Practices Guidance

• Store at or below 25 C (77 F) unless the product label states otherwise
• Keep away from excess heat, moisture and direct sunlight
• Do not freeze unless the label permits freezing
• Retain medicines in their original container and keep out of reach of children and pets

Evaluating Options and Additional options

Choice of an a rival option depends on the host species, the parasite, resistance patterns and legal approval. Typical other routes available in Australia include:

• Albendazole - a broad-spectrum benzimidazole used in humans; usually prescription-only
• Mebendazole - human-use benzimidazole for intestinal worms; some small packs are available as Pharmacy Medicines
• Pyrantel embonate - commonly used for threadworm and available in limited pack sizes as a Pharmacy Medicine for humans
• Praziquantel - effective for many tapeworms; human formulations require a prescription
• Ivermectin - active against various nematodes; human use is prescription-only and veterinary forms are regulated separately
• Milbemycin oxime - often combined with praziquantel in companion animal products available through veterinarians

When comparing options consider formulation, approved clues indicating, dose frequency, and latent capacity cost. For human patients consult a doctor or pharmacist about approved anthelmintics and subsidy options under the Pharmaceutical Benefits Scheme. For animals speak with a veterinarian about licensed products and appropriate dosing.

Price estimates in Australia (AUD)

Listed prices are approximate and vary by brand, pack size and retailer. Confirm current costs with pharmacies, veterinary clinics or reputable online sellers.

• Fenbendazole granule sachets for pets (small multi-sachet packs): about AUD 10 to 30
• Fenbendazole 10 percent oral suspension (100 ml small animal pack): roughly AUD 20 to 45
• Large farm animal suspensions (1 litre and above): commonly AUD 120 to 250 or more depending on concentration
• Mebendazole small human packs: approximately AUD 10 to 20
• Pyrantel embonate for human threadworm (Pharmacy Medicine): typically AUD 8 to 18
• Albendazole for humans (prescription): about AUD 30 to 70 per treatment course
• Ivermectin or praziquantel human prescription products: a typical course often costs in the AUD 20 to 60 range depending on PBS status and dispensing fees

Note: many human anthelmintics require a prescription and may be subsidised under the PBS for eligible patients, which reduces out-of-pocket expense. Veterinary formulations may offer lower per-dose cost for animals but are not intended for human use.

Regulatory and Attorneys' Notes for Australia

• Human approval: fenbendazole is not registered as a human medicine on the Therapeutic Goods Administration (TGA) register.
• Veterinary regulation: fenbendazole-containing products for animals are regulated by the Australian Pesticides and Veterinary Medicines Authority (APVMA) and must be used according to label directions or veterinary prescription.
• Scheduling: several human anthelmintics (such as albendazole, ivermectin, praziquantel) are Schedule 4 prescription medicines. Some products like small mebendazole or pyrantel packs are available as Pharmacy Medicines in limited pack sizes.
• Access to unapproved medicines: clinicians can apply for access through TGA pathways such as the Special Access Scheme or Authorised Prescriber routes. Personal importation is subject to customs and health regulations and may be limited.
• Off-label use and safety: using veterinary fenbendazole for human self-treatment can be unsafe and may contravene regulatory expectations. Always consult a medical practitioner for human health concerns and a veterinarian for animal treatments.

For the latest state and national rules consult TGA and APVMA resources or local health authorities. Cast your gaze on the additional an alternate possibilitys section for human-approved options.

Important Heads Up

• This page offers general information and is not a substitute for advice from a registered medical practitioner, pharmacist, or licensed veterinarian.
• Always confirm diagnosis, species-appropriate dosing and correct product selection with a qualified professional before beginning therapy.
• To return to the topmost layer of this page use the Home link. Review Untoward effects and Regulatory Notes for safety and direction for legal purposes.